Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 2
2018 3
2019 5
2020 7
2021 7
2022 13
2023 19
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.
Nombel A, Fabien N, Coutant F. Nombel A, et al. Front Immunol. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352. eCollection 2021. Front Immunol. 2021. PMID: 34745149 Free PMC article. Review.
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly progressive interstitial lung disease. ...
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clini …
[Anti-MDA5 dermatomyositis. Literature review].
Castro-Molina SA, Méndez-Flores S. Castro-Molina SA, et al. Rev Med Inst Mex Seguro Soc. 2023 Jan 2;61(1):99-105. Rev Med Inst Mex Seguro Soc. 2023. PMID: 36542793 Free PMC article. Review. Spanish.
Anti-MDA5 dermatomyositis: an update from bench to bedside.
Fuzzi E, Gatto M, Zen M, Franco C, Zanatta E, Ghirardello A, Doria A. Fuzzi E, et al. Curr Opin Rheumatol. 2022 Nov 1;34(6):365-373. doi: 10.1097/BOR.0000000000000908. Epub 2022 Sep 12. Curr Opin Rheumatol. 2022. PMID: 36094462 Free PMC article. Review.
PURPOSE OF REVIEW: This review summarizes the recent developments about anti-MDA5 antibody positive dermatomyositis with a focus on its pathogenesis, clinical features and treatment options of rapidly progressive interstitial lung disease, its most ominous complication. RECENT FI …
PURPOSE OF REVIEW: This review summarizes the recent developments about anti-MDA5 antibody positive dermatomyositis with a focus on its path …
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.
Gonzalez D, Gupta L, Murthy V, Gonzalez EB, Williamson KA, Makol A, Tan CL, Sulaiman FN, Shahril NS, Isa LM, Martín-Nares E, Aggarwal R. Gonzalez D, et al. Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4. Rheumatol Int. 2022. PMID: 35661906 Free PMC article. Review.
Dermatomyositis: Diagnosis and treatment.
Waldman R, DeWane ME, Lu J. Waldman R, et al. J Am Acad Dermatol. 2020 Feb;82(2):283-296. doi: 10.1016/j.jaad.2019.05.105. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279813 Review.
Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features.
Kurtzman DJB, Vleugels RA. Kurtzman DJB, et al. J Am Acad Dermatol. 2018 Apr;78(4):776-785. doi: 10.1016/j.jaad.2017.12.010. Epub 2017 Dec 9. J Am Acad Dermatol. 2018. PMID: 29229575 Review.
Melanoma differentiation-associated gene 5 (MDA5) is a recently described autoantigen target in a subset of patients with dermatomyositis. Anti-MDA5 dermatomyositis is characterized by a unique mucocutaneous and systemic phenotype that includes cutaneous and …
Melanoma differentiation-associated gene 5 (MDA5) is a recently described autoantigen target in a subset of patients with dermatomyositis. …
Update on dermatomyositis.
Tanboon J, Nishino I. Tanboon J, et al. Curr Opin Neurol. 2022 Oct 1;35(5):611-621. doi: 10.1097/WCO.0000000000001091. Epub 2022 Aug 4. Curr Opin Neurol. 2022. PMID: 35942671 Review.
These features include but may not be limited to the presence of perifascicular necrosis in anti-Mi-2 dermatomyositis; presence of diffuse nonperifascicular sarcoplasmic myxovirus resistance protein A expression in anti-MDA5 dermatomyositis; and dermatomyosit …
These features include but may not be limited to the presence of perifascicular necrosis in anti-Mi-2 dermatomyositis; presence of diffuse n …
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A, Meyer A, Guillaud C, Limal N, Gagnadoux F, Hervier B, Borie R, Deligny C, Terrier B, Berezne A, Audia S, Champtiaux N, Devilliers H, Voermans N, Diot E, Servettaz A, Marhadour T, Castelain V, Humbert S, Blanchard-Delaunay C, Tieulie N, Charles P, Gerin M, Mekinian A, Priou P, Meurice JC, Tazi A, Cottin V, Miyara M, Grange B, Israël-Biet D, Phin-Huynh S, Bron C, De Saint Martin L, Fabien N, Mariampillai K, Nunes H, Benveniste O; French Myositis Network. Allenbach Y, et al. Neurology. 2020 Jul 7;95(1):e70-e78. doi: 10.1212/WNL.0000000000009727. Epub 2020 Jun 2. Neurology. 2020. PMID: 32487712 Free PMC article.
., skin rash, arthralgia, interstitial lung disease [ILD]) as well as the low frequency of muscle signs in anti-melanoma differentiation-associated gene 5 antibody-positive (anti-MDA5+) dermatomyositis caused us to question the term myositis-specific antibody …
., skin rash, arthralgia, interstitial lung disease [ILD]) as well as the low frequency of muscle signs in anti-melanoma differentiation-ass …
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study.
Castellanos-Gonzalez M, Bris BB, Marsol IB, Campos MM, Ruiz-Villaverde R, Llorente CP, Nuno-Gonzalez A, Sánchez JT, Mur EC, García RG, Alonso AB, Español GA, García YH, Schmidt JMS, Sánchez MA, Crespo ER, Alonso ELH, Gallo-Pineda G, Izquierdo JAA, Varillas-Delgado D. Castellanos-Gonzalez M, et al. J Dtsch Dermatol Ges. 2023 Jul;21(7):741-748. doi: 10.1111/ddg.15089. Epub 2023 May 23. J Dtsch Dermatol Ges. 2023. PMID: 37218533
The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnostic markers for the presence of anti-MDA5 (anti-MDA5(+) ). ...
The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnost …
63 results